Biopharma Automation & AI
Genedata empowers biopharma organizations worldwide with first-in-class enterprise software to innovate boldly, operate efficiently, and accelerate discovery, development, and manufacturing of next-generation medicines.
Driving the Future of Biopharma R&D. Powered by Over 25 Years of Innovation.
Genedata transforms biopharma R&D through automation, advanced analytics, and AI. As the first biologics-native technology company, we lead digitalization and enable data-driven decision-making for biopharma organizations worldwide. The Genedata Biopharma Platform combines a unified data model with workflow automation and embedded AI to accelerate and optimize end-to-end discovery and development of biologics and other modalities.
Our Customers
Innovative. Trusted.
One Data Model
A single, unified data model powering collaboration and innovation
Science-Native
Developed by scientists for scientists, in collaboration with industry leaders
Automation & AI
Automated workflows and embedded AI turning data into intelligence
Proven Solution
Trusted for 25+ years by leading biopharma innovators worldwide
Off-the-Shelf
Ready-to-use and fast to deploy on-premises or SaaS
User Friendly
Complex workflows and stringent standards made easy and intuitive
Future-Proof
Open, scalable, and built on modern technology with compliance at its core
Maximum ROI
Highest value realization, year-over-year, reported by our customers
Connect. Learn. Innovate.
Connect with biopharma leaders, gain actionable insights, and explore the latest strategies in R&D at our annual event. Don’t miss your chance to network with experts from leading companies and discover new approaches that can accelerate your scientific work.
Join us in Boston on March 9–10, 2027, for this year's Genedata Partner Symposium.
Genedata Webinar Week
September 2026
In the fifth edition of Genedata Webinar Week, explore how leading biopharma organizations are applying advanced analytics to accelerate scientific discovery, development, and downstream processing. Hear directly from Novartis, OmniAb, Merck & Co., and Genedata as they share real-world approaches to improving data quality, streamlining analytical workflows, and enabling more confident scientific decisions.
Automation & AI. Biopharma Reimagined.
Automation and AI are key to driving innovation, increasing efficiency, reducing costs and mitigating risk. They are not optional anymore. Genedata has a deep understanding of the complex biopharma R&D workflows, the data, and how it’s used across modalities. We are combining our expertise with a unified, structured data foundation, advanced automation technology and embedded AI to empower our customers to accelerate data workflows, increase scientific productivity, uncover hidden insights and enable scientific breakthrough.
Delivered. On Time. Compliant.
Biopharma companies cannot afford wasting their time to achieve operational efficiency and minimize time to patient. This is why we deliver the solutions they need, and we deliver them on time, always. And our customers have to minimize compliance and quality risks to comply with regulations and to deliver medicines of high quality, safety and efficacy to their patients. This is why we provide a platform with data integrity, traceability, and compliance, built-in by design.
Structured Data. AI Ready.
New robotic systems and laboratory automation have dramatically increased the amount of experimental data for capture, processing, and analysis. Only a truly scalable platform can manage the exponentially growing volume of data, which fuels next-generation artificial intelligence (AI) and machine learning (ML) technologies.
AI approaches such as Deep Learning require systematic access to structured data to extract patterns to guide future R&D projects. Unstructured data repositories, even when centralized, make it impossible to make sense out of the data. Only a fully integrated data infrastructure can transform R&D operations.
AI is here. Are you ready?
We undertook a thorough selection process to find the best antibody workflow platform and Genedata was the obvious choice.
One of the reasons we chose Genedata was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.
We needed a central platform to capture and process data across our global R&D teams, while ensuring full data integrity and traceability, and Genedata was the only solution that ticked all the boxes right from the start.
